Rigopoulou Eirini I, Zachou Kalliopi, Gatselis Nikolaos K, Papadamou Georgia, Koukoulis George K, Dalekos George N
Eirini I Rigopoulou, Kalliopi Zachou, Nikolaos K Gatselis, Georgia Papadamou, Department of Medicine and Research Laboratory of Internal Medicine, Medical School, University of Thessaly, 41110 Larissa, Greece.
World J Hepatol. 2013 Oct 27;5(10):577-83. doi: 10.4254/wjh.v5.i10.577.
To present the characteristics, management and outcome of patients with hepatitis B virus (HBV) or hepatitis C virus (HCV) infections concurrent with primary biliary cirrhosis (PBC).
Since January 2001 to September 2009, we retrospectively evaluated the medical records of all HBV (n = 1493) and HCV patients (n = 526) who are followed in our center for the presence of concurrent PBC. Seventeen patients identified with concurrent viral hepatitis and PBC (8 HCV and PBC; follow-up: 61 ± 37 mo and 9 HBV and PBC; follow-up: 57 ± 38 mo). PBC diagnosis was established if the patients met at least two of the following criteria: positivity for antimitochondrial antibody, elevated cholestatic enzymes and histological lesions of PBC.
HCV or HBV diagnosis preceded that of PBC in most patients by many years. PBC diagnosis was based on the presence of antimitochondrial antibody and elevated cholestatic enzymes in all 17 patients, while one third (5/17; 29.4%) experienced severe pruritus many years before diagnosis. Patients with PBC and HBV were significantly younger at diagnosis of PBC compared to patients with PBC and HCV (56.1 ± 11.2 vs 68.5 ± 10.3, respectively, P < 0.05). At initial clinical and histological assessment the majority of patients were cirrhotics (10/17; 58.8%) with the group of PBC and HCV carrying the highest frequency (87.5% vs 33.3% in PBC and HBV; P < 0.05). The patients with HBV and concomitant PBC seem to have better outcome compared to those with HCV and PBC since none of the 6 non-cirrhotics with HBV and PBC developed cirrhosis during follow-up.
PBC diagnosis in HBV or HCV patients is very difficult and usually delayed. Therefore, in any case, cholestasis should alert physicians to further search for PBC.
介绍合并原发性胆汁性肝硬化(PBC)的乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)感染患者的特征、管理及预后。
自2001年1月至2009年9月,我们回顾性评估了在本中心随访的所有HBV患者(n = 1493)和HCV患者(n = 526),以确定是否合并PBC。17例患者被确诊为合并病毒性肝炎和PBC(8例HCV合并PBC;随访时间:61±37个月;9例HBV合并PBC;随访时间:57±38个月)。如果患者符合以下至少两条标准,则确诊为PBC:抗线粒体抗体阳性、胆汁淤积酶升高及PBC的组织学病变。
大多数患者的HCV或HBV诊断比PBC诊断早很多年。所有17例患者的PBC诊断均基于抗线粒体抗体的存在及胆汁淤积酶升高,而三分之一(5/17;29.4%)的患者在诊断前多年经历过严重瘙痒。与PBC合并HCV的患者相比,PBC合并HBV的患者在PBC诊断时明显更年轻(分别为56.1±11.2岁和68.5±10.3岁,P < 0.05)。在初始临床和组织学评估时,大多数患者为肝硬化患者(10/17;58.8%),PBC合并HCV组的频率最高(87.5%,而PBC合并HBV组为33.3%;P < 0.05)。与HCV合并PBC的患者相比,HBV合并PBC的患者似乎预后更好,因为6例非肝硬化的HBV合并PBC患者在随访期间均未发展为肝硬化。
HBV或HCV患者的PBC诊断非常困难且通常延迟。因此,在任何情况下,胆汁淤积都应提醒医生进一步排查PBC。